AI is revolutionizing oncology drug development, enhancing therapeutic identification and reducing approval times, but use of this tool must be carefully implemented to mitigate risks and ensure regulatory compliance.
Robert J. Paradiso, JD
Advertisement
Articles by Robert J. Paradiso, JD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Announces Recall 580,000 Bottles of Prazosin Over Potential Carcinogenic Impurity
2
Regular Melatonin Supplementation May Hide Hidden Heart Complications
3
Early Detection of Type 1 Diabetes: The Power of Screening and Preparation
4
COVID-19 During Pregnancy Raises Neurodevelopmental Risks in Children
5
